Jump to content

Flufenoxine

From Wikipedia, the free encyclopedia

Flufenoxine
Clinical data
Other namesF-98214-TA
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H20FNO
Molar mass285.362 g·mol−1
3D model (JSmol)
  • C1CNCCC1C(C2=CC=CC=C2)OC3=CC(=CC=C3)F

Flufenoxine (F-98214-TA) is a Serotonin–norepinephrine reuptake inhibitor. It can be used to treat disorders of the central nervous system, particularly depression and anxiety. It was developed by a Spanish company at the beginning of the 21st century.[1]

Flufenoxine derivatives have been patented for the treatment of Alzheimer's disease.[2]

Analogues of Flufenoxine were reported containing a duloxetine-type thiophene surrogate ring moiety.[3] Such agents possess the desired triple-mode of activity (serotonin-noradrenaline and dopamine) (c.f. SNDRI).

Synthesis

[edit]

The synthesis of Flufenoxine was disclosed in a pair of patents:[4][5]

Flufenoxine synthesis
Flufenoxine synthesis

Ex 1: The base catalyzed ether formation between tert-butyl 4-[hydroxy(phenyl)methyl]piperidine-1-carboxylate [269740-46-7] (1) and 1,3-difluorobenzene [372-18-9] (2) gave a racemic mixture of (3).

References

[edit]
  1. ^ Artaiz I, Zazpe A, Innerárity A, Del Olmo E, Díaz A, Ruiz-Ortega JA, et al. (November 2005). "Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties". Psychopharmacology. 182 (3): 400–13. doi:10.1007/s00213-005-0087-3. PMID 16032410.
  2. ^ Francisco Ledo Gómez, et al. WO2011147780 (Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA).
  3. ^ 郭强, et al. WO2015131814 (to WUHAN JIAYU TECHNOLOGY Co Ltd, Nhwa Pharmaceutical Corp).
  4. ^ Venero Aurelio Orjales, et al. EP1002794 (2000 to Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA).
  5. ^ Aurelio Orjales Venero, Ramón MOSQUERA PESTAÑA, Mª Carmen PUMAR DURÁN, Antonio Toledo Avello, Gonzalo Canal Mori, Maravillas Bordell Martín, WO2007131846 (Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA).

Media related to Serotonin–norepinephrine–dopamine reuptake inhibitors at Wikimedia Commons